Oncology / Mantle Cell Lymphoma

Managing Side Effects Associated With Bruton Tyrosine Kinase Inhibitor Therapy

patient care perspectives by Christopher Flowers, MD, MS

Clinical trials have demonstrated the acceptable safety profiles of Bruton tyrosine kinase (BTK) inhibitors in patients with mantle cell lymphoma (......READ MORE

CLL

Sequencing vs Combination of Novel Molecules in the Treatment of Chronic Lymphocytic Leukemia

expert roundtables by Jennifer R. Brown, MD, PhD; Anthony Mato, MD, MSCE; and Susan O’Brien, MD

CLL

Improving Durability of Response in Patients With High-Risk Chronic Lymphocytic Leukemia

expert roundtables by Jennifer R. Brown, MD, PhD; Anthony Mato, MD, MSCE; and Susan O’Brien, MD

LATEST IN Oncology

Browse More Articles